A scientist works at Zai Lab's drug development facility in Shanghai, China October 18, 2017. To match Insight CHINA-BIOTECH/ REUTERS/Adam Jourdan

Biotech start-ups are knocking on Hong Kong’s doors to raise funds

Earlier this month, Michael Chan and several colleagues flew 11 hours to San Francisco to represent Hong Kong’s stock exchange for the first time at JPMorgan Chase & Co’s global Healthcare Conference, attended by more than 10,000 institutional investors, founders of health care start-ups and